MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Operating Cash Flow 2011-2026 | EW
Annual Operating Cash Flow Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.6 B | 542 M | 896 M | 1.22 B | 1.73 B | 1.05 B | 1.18 B | 927 M | 1 B | 704 M | 550 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.73 B | 542 M | 1.04 B |
Quarterly Operating Cash Flow Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 280 M | - | - | - | -53.5 M | - | - | - | 314 M | - | 935 M | - | 293 M | - | 1.36 B | - | 300 M | - | 654 M | 438 M | 207 M | - | 780 M | 343 M | 1.5 M | - | 634 M | 292 M | 151 M | - | 637 M | 326 M | 128 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 14.9 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.36 B | -53.5 M | 402 M |
Operating Cash Flow of other stocks in the Medical devices industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
-4.76 M | - | 37.08 % | $ 85.7 M |  USA |
 |
Axonics Modulation Technologies
AXNX
|
3.19 M | - | - | $ 3.31 B | USA |
 |
Xtant Medical Holdings
XTNT
|
-11.9 M | $ 0.55 | -2.31 % | $ 73.5 M | USA |
 |
Dynatronics Corporation
DYNT
|
301 K | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-44.8 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
-63.1 M | - | -26.83 % | $ 2.62 M | USA |
 |
Zimmer Biomet Holdings
ZBH
|
1.59 B | $ 88.57 | -0.65 % | $ 18 B | USA |
 |
Allied Healthcare Products
AHPI
|
-4.1 M | - | 3.58 % | $ 2.21 M | USA |
 |
Alphatec Holdings
ATEC
|
45.2 M | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
Conformis
CFMS
|
-50.2 M | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
2.86 M | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Cardiovascular Systems
CSII
|
-24.3 M | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-24.3 M | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
-31.3 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-14.4 M | - | -20.74 % | $ 369 K | USA |
 |
CONMED Corporation
CNMD
|
171 M | $ 34.58 | -5.62 % | $ 1.07 B | USA |
 |
NanoVibronix
NAOV
|
-2.52 M | - | - | $ 1.08 M | USA |
 |
Neovasc
NVCN
|
-27.1 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
-14.4 M | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
-7.65 M | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
BIOLASE
BIOL
|
-14.1 M | - | -13.19 % | $ 166 K | USA |
 |
AdaptHealth Corp.
AHCO
|
602 M | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-4.85 M | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
-55.3 M | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-22.6 M | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
-14.5 M | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
239 M | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
117 M | $ 50.13 | -0.63 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
-32.4 M | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
-138 M | - | -10.19 % | $ 1.99 M | USA |
 |
Eargo
EAR
|
-117 M | - | - | $ 10.2 M | USA |
 |
NuVasive
NUVA
|
169 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-19.4 M | - | - | $ 217 M | USA |
 |
Surgalign Holdings
SRGA
|
-52.1 M | - | -32.98 % | $ 1.68 M | USA |
 |
STRATA Skin Sciences
SSKN
|
-1.11 M | - | - | $ 6.6 M | USA |
 |
GBS
GBS
|
-9.68 M | - | -0.57 % | $ 7.12 M | USA |
 |
AVITA Medical
RCEL
|
-31.2 M | $ 3.82 | -1.04 % | $ 106 M |  Australia |
 |
AxoGen
AXGN
|
812 K | $ 31.28 | -3.01 % | $ 1.44 B | USA |
 |
Delcath Systems
DCTH
|
22.5 M | $ 8.97 | -1.75 % | $ 321 M | USA |